Fennec Pharmaceuticals Inc.

News & Events

Press Releases

In The Media

1. Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

   GlobeNewswire MAY 13, 2025 6:03 AM EDT
   ~ Achieved First Quarter 2025 Total Net Revenues of $8.8 Million, Up 18% Year Over Year ~ ...
   READ ARTICLE

2. Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

   GlobeNewswire MAY 8, 2025 4:17 PM EDT
   RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDA...
   READ ARTICLE

3. Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

   GlobeNewswire MAR 10, 2025 6:03 AM EDT
   ~ Achieved Full-Year PEDMARK ® Net Product Sales of $29.6 Million, Up 40% Year-O...
   READ ARTICLE

4. Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025

   GlobeNewswire MAR 6, 2025 4:22 PM EST
   RESEARCH TRIANGLE PARK, N.C., March 06, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NAS...
   READ ARTICLE

5. Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

   GlobeNewswire FEB 7, 2025 7:00 AM EST
   ~ PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prev...
   READ ARTICLE

6. Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

   GlobeNewswire DEC 20, 2024 6:16 AM EST
   ~ PEDMARQSI ® (anhydrous sodium thiosulfate) is the first and only treatment availab...
   READ ARTICLE

7. Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management

   GlobeNewswire DEC 19, 2024 6:13 AM EST
   ~ $13 Million Convertible Debt Repayment from Available Cash ~ ~ Elimination of Approxima...
   READ ARTICLE

8. Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

   GlobeNewswire DEC 12, 2024 7:01 AM EST
   RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASD...
   READ ARTICLE

9. Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

   GlobeNewswire NOV 13, 2024 6:27 AM EST
   RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASD...
   READ ARTICLE

10. Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

    GlobeNewswire NOV 7, 2024 6:13 AM EST
    ~ Achieved Third Quarter 2024 Net Product Sales of $7.0 Million ~ ~ Increasing Momentum a...
    READ ARTICLE